C2406

JW Pharmaceutical · Phase 1 active Small molecule

At a glance

Generic name	C2406
Sponsor	JW Pharmaceutical
Modality	Small molecule
Phase	Phase 1

Approved indications

No approved indications tracked.

Common side effects

No common side effects on file.

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

C2406 CI brief — competitive landscape report
C2406 updates RSS · CI watch RSS
JW Pharmaceutical portfolio CI